Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Harpoon Therapeutics Inc (HARP)

  7. Harpoon Therapeutics Inc (HARP) Financials

HARP

Harpoon Therapeutics Inc

0.79
0.0129 (1.66%)
Upgrade to Real-Time

Harpoon Therapeutics Inc. (HARP) Fundamentals
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.
SHARE INFORMATION
Market Cap$ 28,948,756
Shares Outstanding37,595,787
Float24,280,000
Percent Float64.58%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 8,583,000
Latest Fiscal EPS$ -0.31
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions180
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months880,953
Institutional Holdings Percent64.7%
Institutional Sold Previous 3 Months5,015,087
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months582,600
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned417,600
TRADING INFO
52 Week High$ 3.35
52 Week Low$ 0.54
52 Week High Change$ -69.92
21 Day Moving Average$ 0.7569
21 Day Extended Moving Average$ 0.737088
50 Day Moving Average$ 0.6921
50 Day Extended Moving Average$ 0.724986
200 Day Moving Average$ 0.892054
200 Day Extended Moving Average$ 1.3002
10 Day Average Volume210,138
20 Day Average Volume178,889
30 Day Average Volume178,774
50 Day Average Volume192,853
Alpha-0.044776
Beta1.5380
Standard Deviation0.239464
R20.121742
7 Day Price Change$ 0.0852
7 Day Percent Change12.44%
21 Day Price Change$ -0.0288
21 Day Percent Change-3.61%
30 Day Price Change$ 0.0886
30 Day Percent Change13.0%
Month to Date Price Change$ 0.09
Month to Date Percent Change13.24%
Quarter to Date Price Change$ 0.0258
Quarter to Date Percent Change3.47%
180 Day Price Change$ -0.1863
180 Day Percent Change-19.48%
200 Day Price Change$ 0.0398
200 Day Percent Change5.45%
Year to Date Price Change$ 0.0443
Year to Date Percent Change6.1%

Harpoon Therapeutics Inc. (HARP) Key Ratios

PROFITABILITY
EBIT Margin-172.5%
EBITDA Margin-173.7%
Pre-Tax Profit Margin-357.5%
Profit Margin Count-1.32%
Gross Margin36.6%
Profit Margin TOT-1.32%
INCOME STATEMENTS
Revenue$ 8,583,000
Revenue Per Share$ 0.2283
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book41.30
Total Debt To Equity21.80
Int Coverage0.00
Current Ratio1.50
Leverage Ratio113.00
Quick Ratio1.40
Long Term Debt To Capital0.95
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ -16,564,314
Price to Sales0.85
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book41.30
Price To Cash Flow-0.40
PE Low Last 5 Years0.00
Price to Tangible Book41.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.30
Return Assets-55.07
Return on Equity-278.96
Return on Capital-171.68

Harpoon Therapeutics Inc. (HARP) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOJulie Eastland
Employees95
Last Audit-
CIK0001708493
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address131 Oyster Point Boulevard,Suite 300
Suite 300
South San Francisco, CA 94080
Websitehttps://www.harpoontx.com
Facsimile-
Telephone+1 650 443-7400
Emailinfo@harpoontx.com


Your Recent History
NASDAQ
HARP
Harpoon Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.